Tag: sun_pharmaceutical_industries

Sun Pharma Recalls Cancer Drug Over Glass Particles

14 May 2026 4:17 p.m. · Source: US Food and Drug Administration

Sun Pharma is recalling one batch of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL in the U.S. due to glass particles. The drug, used for various cancers, poses risks of irritation and blood clots, though no adverse events have been reported.

Health Business Medical Science Federal Government Legal Product Recall Sun Pharmaceutical Industries DOXOrubicin Hydrochloride Liposome Injection Glass particles Pharmaceuticals Cancer FDA Food Recalls Drugs
Sun Pharma Recalls Doxorubicin Injection Over Glass Particle Risk

14 May 2026 7:33 a.m. · Source: US Food and Drug Administration

Sun Pharmaceutical Industries is recalling a batch of DOXOrubicin Hydrochloride Liposome Injection in the U.S. due to potential glass particles. This recall affects 675 vials, posing risks like blood clots, though no adverse events have been reported.

Health Business Politics and Government Medical Science Legal Education Federal Government Product Recall Pharmaceuticals Oncology Medication Safety Sun Pharmaceutical Industries DOXOrubicin Food Recalls FDA Drugs